RSV Vaccine: 4 Questions Answered
The world’s first RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.
The world’s first RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.
Arexvy is expected to be available for the 2023-2024 RSV season.
This age group is now eligible to receive the booster dose at least 2 months after they complete primary vaccination with 3 doses of the monovalent vaccine.
Approximately 25% of parents lie about their child’s COVID-19 vaccine status or don’t quarantine their children, survey findings show.
M-M-R II, Varivax, and ProQuad are supplied in single-dose vials as lyophilized vaccine for SC or IM injection after reconstitution.
Several changes have been made to the adult immunization schedule 2023.
Several changes have been made to the child and adolescent immunization schedule for 2023.
The preliminary safety signal was identified by the CDC’s Vaccine Safety Datalink.
The bivalent formulations contain the original strain of the SARS-CoV-2 virus and a strain from the BA.4 and BA.5 lineages of the Omicron variant.
The rate of children receiving a first measles-containing vaccine decreased between 2020 and 2021, CDC says.